Kawakami Y. Development of new immunotherapy using cancer antigens recognized by T-lymphocytes. In “New Strategy for Cancer Treatment”, Proceedings of the 3rd Shizuoka Forum on Health and Longevity :62-68.2000
Kawakami Y, Dang N, Wang X, Tupesis J, Robbins PF, Wang RF, Wunderlich JR, Yannelli JR and Rosenberg SA. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J Immunother.23(1):17-27.2000 Jan
Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y and Kawakami Y. T cells that are autoreactive to b2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.Arthritis Rheum.43(1):65-75.2000 Jan
Kuwana M, Kaburaki J, Mimori T, Kawakami Y and Tojo T. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis Rheum.43(5):1074-1084.2000 May
Kawakami Y. Immunotherapy of melanoma using T cell defined antigens. in “Cell Therapy” Ikeda, Y, Hata, J, Koyasu, S, Kawakami, Y, Hattori, Y, eds. Keio University Symosia for Life Sciences and Medicine, Springer, Tokyo,.5:77-92.2000
Kawakami Y. Suzuki Y, Shofuda T, Kiniwa Y, Inozume T, Dan K, Sakurai T and Fujita T.T cell responses to melanoma and melanocytes. Pigment Cell Research.13(Suppl 8):163-169.2000
Kawakami Y. New cancer therapy by immunomanipulation: Development of immunotherapy for human melanoma as a model system.Cornea.19(3-Sppl 1):S2-S6.2000 May
Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H and Ikeda Y. .HLA class II alleles in Japanese patients with immune thrombocytopenic purpura: associations with anti-platelet glycoprotein antibodies and responses to splenectomy. Tissue Antigens.56(4):337-343.2000 Oct